Answers are grounded in this paper and cite their sources.
Review reveals links between vitamin D deficiency and disease activity in multiple sclerosis, highlighting its therapeutic potential.
Initially recognised as an important factor for bone health, vitamin D is now known to have a range of effects on the immune system. Vitamin D deficiency is associated with an increased risk of multiple sclerosis (MS), a chronic immune-mediated demyelinating disease of the CNS. In this review, we explore the links between vitamin D deficiency, MS risk, and disease activity. We also discuss the known immune effects of vitamin D supplementation and the relevance of these observations to the immunopathology of MS. Finally, we review the existing evidence for vitamin D supplementation as an MS therapy, highlighting several recent clinical studies and trials.
No takes yet. Share an insight, caveat, or question.
Yeh et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: